Navigation Links
Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor
Date:7/22/2014

(PRWEB) July 22, 2014

The European Bio stimulants Market report defines and segments the bio stimulants market in Europe with analysis and forecast of revenue. The bio stimulants market in Europe is estimated to grow from around $528.5 million in 2013 to $940.6 million by 2018, at a CAGR of 12.2% from 2013 to 2018.

Browse through the TOC of the Europe Bio stimulants Market report, to get an idea of the in-depth analysis provided.
http://www.micromarketmonitor.com/market/europe-bio-stimulants-1315565884.html

Agriculture contributes to 10% of the European Union’s GDP, as estimated in 2012. The chief agriculture produce is exported to the RoW, from EU. It is the world’s biggest cereals producer that include maize, barley, rye, oats, and so on. The increasing land degradation and the growing need for high quality and productivity of crops pressurizes the leading exporting countries for agriculture produce. Also, the demand for organic produce and the need to avoid environmental pollution by agriculture input is increasing. Hence, the consumption of bio-stimulants is expected to increase in Europe.

Early buyers will receive 10% customization on this report.
http://www.micromarketmonitor.com/contact/1315565884-request_for_customization.html

Spain is the market leader of bio-stimulants in Europe with a market share of around 24.0% as recorded in 2013. Italy is expected to be the fastest-growing market, at a CAGR of 12.5% during the period 2013 to 2018.

This market is segmented and forecast on the basis of ingredients of bio stimulants, such as acids, extracts, and so on. The market is further segmented and forecast on the basis of major countries, such as the Spain, Italy, France, and the U.K., among others.

Get a copy of PDF Brochure at http://www.micromarketmonitor.com/contact/1315565884-download_pdf_brochure.html.

This report also includes the market share, supply chain and value chain analyses, and market metrics such as drivers and restraints. In addition, it presents a competitive landscape and company profiles of the key players in the market.

Related Reports:

North America Bio Stimulants Market
The bio stimulants market in North America was valued at $0.27 billion in 2013, and is expected to grow at a CAGR of 12.4% annually, to reach $0.49 billion by 2018. This market constitutes 21.5% of the global bio stimulants market. The major types of this market include Acids, Extracts, and others comprising 54.2%, 40.7%, and 5.1% respectively, of the North American bio stimulants market. The most important macro indicators of this market is Agricultural Land. The North American bio stimulants market can be segmented in terms of companies, end-users, applications, and macro indicators.

This report provides a competitive landscape of the top players of the bio stimulants market in North America. Under the strategic bench marking section, we will provide you with their key developments along with the impacts that include new product developments, M&A, a strategic focus on any specific application, technology, and geography. Under the Financials section, we will provide you with details that span Capex (Investments), revenues, EBITDA, and so on.
http://www.micromarketmonitor.com/market/north-america-bio-stimulants-6850160039.html

Asia Bio Stimulants Market
The bio stimulants market in Asia-Pacific was valued at $0.25 billion in 2013, and is expected to grow at a CAGR of 12.9% annually, to reach $0.47 billion by 2018. This market constitutes 20% of the global bio stimulants market. The major segments of this market include bio insecticides, bio fungicides, and bio herbicides, among others, comprising 51.8%, 37.9%, and 10.2%, respectively, of the Asia-Pacific market. The Asian bio stimulants market can be segmented by companies, end-users, applications, and macro indicators.

This report provides a competitive landscape of the top players in the Asian bio stimulants market. Under the strategic bench marking section, we will provide you with their key developments along with the impacts that include new product developments, M&A, a strategic focus on any specific application, technology, and geography. Under the Financials section, we will provide you with details that span Capex (Investments), revenues, EBITDA, and so on. Under the operational insights section, we will provide you with the new capacities added, new centers, and new key employments.
http://www.micromarketmonitor.com/market/asia-bio-stimulants-8666578709.html

Latin America Bio Stimulants Market
The bio stimulants market in Latin America was valued at $0.16 billion in 2013, and is expected to grow at a CAGR of 14.4% annually, to reach $0.32 billion by 2018. This market constitutes 12.9% of the global bio stimulants market. The major segments of the bio stimulants market in Latin America are bio insecticides, bio fungicides, and bio herbicides, among others, comprising 52.3%, 38.8% and 8.9% share, respectively, of the market. The Latin American market can also be segmented by companies, end-users, applications, and macro indicators.

This report provides a competitive landscape of the top players of the Latin American bio stimulants market. Under the strategic bench marking section, we will provide you with their key developments along with the impacts that include new product developments, M&A, a strategic focus on any specific application, technology, and geography. Under the Financials section, we will provide you with details that span Capex (Investments), revenues, EBITDA, and so on. Under the operational insights section, we will provide you with the new capacities added, new centers, and new key employments. Under the sales and marketing section, we will provide you with insights on new contracts (available on the public domain), new distribution channels added, new marketing initiatives, and so on.
http://www.micromarketmonitor.com/market/latin-america-bio-stimulants-6148072228.html

About MicroMarket Monitor:

MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.

Contact:
Mr. Chandrasekhar K.
5601 Bridge Street
Suite 300
Fort Worth, TX 76112
Tel: +1-888-502-0539
Email: sales(at)micromarketmonitor(dot)com
Connect with us on LinkedIn at http://www.linkedin.com/company/micromarketmonitor.

Read the full story at http://www.prweb.com/releases/bio-stimulants/market/prweb12036810.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Cancer Care Costs Higher in U.S. Than Europe, But Survival Longer
2. Life expectancy and healthy life years in the European Union, 2008-2010
3. U.S. Bests Canada, Europe in Drug Approvals
4. Coronary rehabilitation programs in Europe are underused
5. ESC says 50 percent of CVD deaths in Europe could be avoided with proper regulation
6. Leading cancer specialists from Europe and beyond recognized at ESMO 2012
7. ESC analysis reveals arrhythmia treatment gaps between Eastern and Western Europe
8. SAGE to launch United European Gastroenterology Journal
9. First comprehensive review of European breast cancer screening programs finds benefits outweigh harm
10. Biggest European health study identifies key priorities in 26 cities
11. BMJ and Daily Telegraphs fake hip exposes failing European device regulation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... philanthropic community at its 10th anniversary Fashion Luncheon on Monday, February 8, 2016. ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... 2016 — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... life cycle of pharmaceutical products, garnering increased attention from all stakeholders in the ...
(Date:2/12/2016)... ... , ... As a former television executive, owner Tal Rabinowitz knows how stressful ... decompress, Rabinowitz found herself drawn to a casual meditation class while working at NBC ... implementing a 20-minute-per-day meditation practice with her team. After her tenure at NBC, she ...
(Date:2/12/2016)... ... February 12, 2016 , ... T.E.N., ... have closed for the ISE Southeast Awards 2016. Finalists and winners of the ... ISE® Southeast Executive Forum and Awards Gala on March 15, 2016 at the ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... a Service (WaaS), today announced the integration of Clarity Intelligence Platform (CIP) into ... partners to offer real-time business intelligence (BI) to their small and medium business ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... , 12 februari 2016 AAIPharma ... toonaangevende leverancier van productie en ontwikkeling op ... kondigt vandaag een uitbreiding aan van steriele ... locatie in Charleston, SC ... tot meerdere recente investeringen. http://photos.prnewswire.com/prnh/20150806/256637LOGO ...
(Date:2/12/2016)... February 12, 2016 ... titled Chronic Inflammation Global Clinical Trials Review, H2, ... the global clinical trials landscape along with top ... Region, Country (G7 & E7), Trial Status, Trial ... reviews top companies involved and enlists all trials ...
(Date:2/11/2016)... , Feb. 11, 2016 Stem cells ... are characterized by self-renewal and the capacity to differentiate ... relatively new discovery, as the first mouse embryonic stem ... was not until 1995 that the first culturing of ... stem cells were not produced until 2006 As a ...
Breaking Medicine Technology: